Hi-Tech Pharmacal Recalls Subpotent Giltuss and Exactuss Cough Medicines
Hi-Tech Pharmacal is recalling specific lots of Giltuss and Exactuss cough and cold medicines because they contain less phenylephrine than labeled.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences, aligning with the Moderate severity rubric for minor labeling or potency issues.
Plain-English summary
Hi-Tech Pharmacal Co., Inc. is recalling 50,848 bottles of Giltuss Antitussive Expectorant and Nasal Decongestant (1 fl. oz. and 8 fl. oz.) and Exactuss Antitussive Expectorant and Nasal Decongestant (16 fl. oz.). The products were manufactured for Gil Pharmaceutical Corp. and distributed in Puerto Rico.
The recall was initiated because the affected lots are subpotent, meaning they contain less phenylephrine HCl than the amount stated on the label. The specific lots involved are Batch/Lot 615688 (exp. 06/2014) and Batch/Lot 617689 (exp. 11/2014) for the 1 fl. oz. and 8 fl. oz. sizes, and Batch/Lot 615649 (exp. 05/2014) for the 16 fl. oz. size.
Consumers who have these specific products should stop using them and return them to the place of purchase or contact the recalling firm for instructions.
The recalled product
- Product
- GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 1 fl. oz. (NDC 58552-122-01) and 8 fl. oz. (NDC 58552-122-08), and EXACTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 16 fl. oz. (NDC 58552-125-16) --- Manufactured for: GIL PHARMACEUTICAL CORP. PONCE, PUERTO RICO…
- Manufacturer
- Hi-Tech Pharmacal Co., Inc.
- Category
- Drug — Cough and Cold Medicine
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 16 fl. oz: Batch/Lot 615649 (exp. 05/2014).
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Hi-Tech Pharmacal Co., Inc.
See all →- LowHi-Tech Pharmacal Recalls Liquid Vitamin C Due to pH Issues
FDA (Food) · 2016-12-28
- LowHi-Tech Pharmacal Recalls Liquid Vitamin C Due to Low Active Ingredient
FDA (Food) · 2016-12-28
- ModerateHi-Tech Pharmacal Recalls Ferrous Sulfate Elixir Due to pH Issues
FDA (Food) · 2015-03-11
- SevereHi-Tech Pharmacal Recalls HydrOXYzine Hydrochloride Oral Solution Due to Impurity
FDA (Drugs) · 2014-11-05
- LowHi-Tech Pharmacal Recalls Acyclovir Oral Suspension for Stability Failures
FDA (Drugs) · 2014-01-01
Same hazard · subpotent
See all →- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- HighCompounded vasopressin syringes recalled as subpotent by IntegraDose Compounding Services
FDA (Drugs) · 2026-06-24
- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
Similar recalls
- ModerateHi-Tech Pharmacal Recalls Subpotent Bucalsep Oral Solution
FDA (Drugs) · 2013-05-22
- LowHi-Tech Pharmacal Recalls Subpotent Acetic Acid Otic Solution
FDA (Drugs) · 2013-05-08
- ModerateHi-Tech Pharmacal Recalls Subpotent HydrOXYzine Hydrochloride Oral Solution
FDA (Drugs) · 2013-06-26
- LowPoly Pharmaceuticals Recalls Lortuss Ex Due to Labeling and Specification Issues
FDA (Drugs) · 2014-07-23
- SevereLlorens Pharmaceutical Recalls Urin D/S Tablets Due to Potency Issues
FDA (Drugs) · 2017-11-22
- LowAdvanced Pharma Recalls Oxytocin Injectable Solution Due to Superpotent Drug Concerns
FDA (Drugs) · 2019-02-27